Hitoshi Hanamoto

716 total citations
29 papers, 422 citations indexed

About

Hitoshi Hanamoto is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Hitoshi Hanamoto has authored 29 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Oncology and 9 papers in Immunology. Recurrent topics in Hitoshi Hanamoto's work include Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). Hitoshi Hanamoto is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers) and Immune Cell Function and Interaction (5 papers). Hitoshi Hanamoto collaborates with scholars based in Japan, Sweden and Canada. Hitoshi Hanamoto's co-authors include Osamu Yoshie, Akihisa Kanamaru, Takashi Nakayama, Kunio Hieshima, Daisuke Nagakubo, Yuri Kawasaki, Yoichi Tatsumi, Yasuyoshi Morita, N Arita and Junji Kamogawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Immunology.

In The Last Decade

Hitoshi Hanamoto

26 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Hanamoto Japan 9 249 146 75 68 55 29 422
Agapitos Patakas United Kingdom 10 316 1.3× 76 0.5× 45 0.6× 50 0.7× 96 1.7× 12 425
Jack Treml United States 10 284 1.1× 85 0.6× 76 1.0× 113 1.7× 31 0.6× 14 434
Loui Madakamutil United States 10 404 1.6× 99 0.7× 31 0.4× 42 0.6× 41 0.7× 18 521
Takuro Kuriyama Japan 10 180 0.7× 96 0.7× 35 0.5× 62 0.9× 22 0.4× 49 396
Robin Dart United Kingdom 8 425 1.7× 108 0.7× 50 0.7× 60 0.9× 34 0.6× 21 578
Josquin Nys United Kingdom 8 298 1.2× 37 0.3× 27 0.4× 76 1.1× 42 0.8× 13 414
Gerdien Mijnheer Netherlands 9 381 1.5× 76 0.5× 56 0.7× 171 2.5× 73 1.3× 13 593
Nino Porakishvili United Kingdom 12 235 0.9× 58 0.4× 75 1.0× 73 1.1× 17 0.3× 27 355
Virginie Driss France 10 348 1.4× 146 1.0× 17 0.2× 101 1.5× 106 1.9× 16 613
T Nakagawa Japan 10 427 1.7× 80 0.5× 51 0.7× 82 1.2× 37 0.7× 14 576

Countries citing papers authored by Hitoshi Hanamoto

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Hanamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Hanamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Hanamoto more than expected).

Fields of papers citing papers by Hitoshi Hanamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Hanamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Hanamoto. The network helps show where Hitoshi Hanamoto may publish in the future.

Co-authorship network of co-authors of Hitoshi Hanamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Hanamoto. A scholar is included among the top collaborators of Hitoshi Hanamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Hanamoto. Hitoshi Hanamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanaka, Hirokazu, Ryosuke Fujiwara, Yasuyoshi Morita, et al.. (2025). Antipsychotic Chlorpromazine Suppresses STAT5 Signaling, Overcomes Resistance Mediated by the Gatekeeper Mutation FLT3-ITD/F691L, and Synergizes with Quizartinib in FLT3-ITD-Positive Cells. Current Issues in Molecular Biology. 47(10). 797–797.
2.
Fujiwara, Ryosuke, Yasuhiro Taniguchi, Shinya Rai, et al.. (2022). Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Biochemical and Biophysical Research Communications. 626. 156–166. 10 indexed citations
3.
Morita, Yasuyoshi, Yasuhito Nannya, Motoshi Ichikawa, et al.. (2022). ASXL1 mutations with serum EPO levels predict poor response to darbepoetin alfa in lower-risk MDS: W-JHS MDS01 trial. International Journal of Hematology. 116(5). 659–668.
4.
Sakurai, Yoshihiko, Masayuki Kubo, Mikio Kamioka, et al.. (2022). QUESTIONNAIRE SURVEY ON AWARENESS OF BLOOD TRANSFUSION THERAPY AMONG MEDICAL PROFESSIONALS IN NARA PREFECTURE. Japanese Journal of Transfusion and Cell Therapy. 68(1). 34–42.
5.
6.
Rai, Shinya, Hiroaki Inoue, Kazuko Sakai, et al.. (2021). Decreased expression of T‐cell‐associated immune markers predicts poor prognosis in patients with follicular lymphoma. Cancer Science. 113(2). 660–673. 11 indexed citations
7.
Hotta, Masaaki�, Atsushi� Satake, Hideaki� Yoshimura, et al.. (2021). Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(8). 660.e1–660.e8. 6 indexed citations
8.
Fukuda, Shuichi, Tomoko Wakasa, Hitoshi Hanamoto, et al.. (2020). Occult follicular lymphoma in a swollen regional lymph node of gastric schwannoma. SHILAP Revista de lepidopterología. 6(1). 232–232. 1 indexed citations
9.
Tsujie, Masanori, Tomoko Wakasa, Kotaro Kitani, et al.. (2020). Isolated myeloid sarcoma presenting with small bowel obstruction: a case report. SHILAP Revista de lepidopterología. 6(1). 2–2. 8 indexed citations
10.
Hanamoto, Hitoshi, Yasuyoshi Morita, Motoshi Ichikawa, et al.. (2020). ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study. Blood. 136(Supplement 1). 28–29. 1 indexed citations
11.
Morita, Yasuyoshi, Yasuhiro Maeda, Terufumi Yamaguchi, et al.. (2018). Five‐day regimen of azacitidine for lower‐risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single‐arm phase 2 trial. Cancer Science. 109(10). 3209–3215. 10 indexed citations
12.
13.
Taniguchi, Yasuhiro, Hirokazu Tanaka, J. Luis Espinoza, et al.. (2017). Elevated plasma levels of procoagulant microparticles are a novel risk factor for thrombosis in patients with myeloproliferative neoplasms. International Journal of Hematology. 106(5). 691–703. 23 indexed citations
14.
Fukuda, Shuichi, Yoshinori Fujiwara, Hiroshi Mishima, et al.. (2017). Choroidal metastasis from granulocyte colony‐stimulating factor‐producing esophageal squamous cell carcinoma: a case report. Clinical Case Reports. 5(4). 419–424. 6 indexed citations
15.
Hanamoto, Hitoshi, et al.. (2016). Premedication with midazolam in intellectually disabled dental patients: intramuscular or oral administration? A retrospective study. Medicina oral, patología oral y cirugía bucal. 21(4). 0–0. 7 indexed citations
16.
17.
Nakatsuka, Shin‐ichi, Zhiming Dong, Tetsuya Takakuwa, et al.. (2004). NK‐cell related neoplasms in Osaka, Japan. American Journal of Hematology. 76(3). 230–235. 8 indexed citations
18.
Hanamoto, Hitoshi, Takashi Nakayama, Kunio Hieshima, et al.. (2004). Expression of CCL28 by Reed-Sternberg Cells Defines a Major Subtype of Classical Hodgkin's Disease with Frequent Infiltration of Eosinophils and/or Plasma Cells. American Journal Of Pathology. 164(3). 997–1006. 54 indexed citations
19.
Morita, Yasuyoshi, Mitsuhiro Matsuda, Hitoshi Hanamoto, et al.. (2004). A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine–CX3CR1 system. Clinical Immunology. 113(1). 109–116. 3 indexed citations
20.
Nakatsuka, Shin‐ichi, Hitoshi Hanamoto, Yoichi Tatsumi, et al.. (2002). Follicular Lymphoma in Osaka, Japan: Histological Features and Chronological Change. International Journal of Hematology. 76(4). 333–337. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Agapitos Patakas Breakdown of academic impact, for papers by Jack Treml Breakdown of academic impact, for papers by Loui Madakamutil Breakdown of academic impact, for papers by Takuro Kuriyama Breakdown of academic impact, for papers by Robin Dart Breakdown of academic impact, for papers by Josquin Nys Breakdown of academic impact, for papers by Gerdien Mijnheer Breakdown of academic impact, for papers by Nino Porakishvili Breakdown of academic impact, for papers by Virginie Driss Breakdown of academic impact, for papers by T Nakagawa
Rankless by CCL
2026